|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 1.690 SEK | +2.05% |
|
-3.76% | +313.20% |
| 08-11 | Moberg Pharma AB Announces Management Changes | CI |
| 07-20 | Medivir Receives Notice of Allowance for Fostrox Plus Lenvatinib Combination Patent in the Usa | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq Stockholm
MVIR B 1.690 kr
+2.05%
1.56M
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq Stockholm
| MVIR B | 1.690SEK | +2.05% | 1.56M kr | |
CBOE
| MVIRBs | 1.698SEK | +2.23% | 39.2K kr | |
|
London S.E.
| 0GP7 | 1.790SEK | -70.27% | 17.9K kr | |
|
Boerse Muenchen
| MVR0 | 0.1726EUR | +12.81% | 34.52 € | |
|
Deutsche Boerse AG
| MVR0 | 0.1100EUR | -4.18% | 0 € | |
|
CBOE
| 0GP7 | 1.634SEK | 0.00% | 0 kr | |
|
Börse Stuttgart
| MVR0 | 0.1472EUR | +4.25% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 1.746 | 2.77 | 2.58 |
| Spread/Res. | -3.21% | -38.99% | -34.50% |
| Spread/Supp. | +2.05% | +36.07% | +70.67% |
| Support | 1.656 | 1.242 | 0.9902 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MVIR B Stock
- Charts Medivir AB
Select your edition
All financial news and data tailored to specific country editions
